Drug intelligence / Profile preview

soap free cleanser + clindamycin + tretinoin

Development stage
Unknown
Lead developer
Stiefel
Modality
Small Molecules
Administration
Topical
01

Overview

This therapeutic regimen, developed by Stiefel (a GSK company), consists of a non-medicated soap-free cleanser used in conjunction with a fixed-dose combination topical gel containing clindamycin phosphate (1%) and tretinoin (0.025%), commercially known as Veltin. Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby suppressing the growth of *Cutibacterium acnes* and reducing inflammation. Tretinoin is a retinoid that binds to nuclear retinoic acid receptors (RARs) to normalize follicular keratinization and promote comedolysis, preventing the formation of new acne lesions. The inclusion of a soap-free cleanser in the regimen is designed to maintain skin barrier integrity and minimize the localized irritation and dryness frequently associated with topical retinoid and antibiotic therapy. This specific combination was evaluated in Phase 3B clinical trials for the treatment of mild to moderate facial acne vulgaris.

Brand names
Veltin
Other names
Soap Free Cleanser and CTGelClindamycin 1%-Tretinoin 0.025% Gel and Soap Free CleanserClindamycin-Tretinoin Gel and Soap Free Cleanser
02

Targets

Bacterial 50S ribosomal subunitRARA (Retinoic acid receptor alpha)

Beyond the preview

Go deeper on soap free cleanser + clindamycin + tretinoin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on soap free cleanser + clindamycin + tretinoin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call